✦ LIBER ✦

Botulinum Toxin Type A Prophylactic Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Exploratory Study

✍ Scribed by Sheena K. Aurora; Marek Gawel; Jan L. Brandes; Suriani Pokta; Amanda M. VanDenburgh; for the BOTOX North American Episodic Migraine Study Group

Book ID: 109099789
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 158 KB
Volume: 0
Category: Article
ISSN: 0017-8748
DOI: 10.1111/j.1526-4610.2006.00624.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind, Randomized, Placebo-Cont

A Double-Blind, Randomized, Placebo-Controlled Comparison of Botulinum Toxin Type A Injection Sites and Doses in the Prevention of Episodic Migraine

✍ Joel R. Saper; Ninan T. Mathew; Elizabeth W. Loder; Ronald DeGryse; Amanda M. Va 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Botulinum Toxin Type A (BOTOX®) for the

Botulinum Toxin Type A (BOTOX®) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Ninan T. Mathew; Benjamin M. Frishberg; Marek Gawel; Rozalina Dimitrova; John Gi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Botulinum toxin type-A in the prophylact

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

✍ Giorgio Sandrini; Armando Perrotta; Cristina Tassorelli; Paola Torelli; Filippo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Botulinum Toxin Type A for the Treatment

Botulinum Toxin Type A for the Treatment of Glabellar Lines in Chinese: A Double-Blind, Randomized, Placebo-Controlled Study

✍ YAN WU; GUANG ZHAO; HENGJIN LI; ZHIZHONG ZHENG; SHAOMIN ZHONG; ZHIYONG YANG; ZHE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Patient-Reported Outcomes with Botulinum

Patient-Reported Outcomes with Botulinum Toxin Type A Treatment of Glabellar Rhytids: A Double-Blind, Randomized, Placebo-Controlled Study

✍ STEVEN FAGIEN; SUE ELLEN COX; J. CHARLES FINN; W. PHILIP WERSCHLER; JONATHAN W. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 857 KB

Botulinum toxin type A for drooling in P

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla